Gilead Sciences, Inc
Held by 18 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 375558103 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 18 of the investors we track own this stock. In the latest quarter, 8 of them bought more of it and 8 sold some or all of theirs. That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
18
0 vs last quarter (like-for-like)
Total value held
$8.37B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
0.3%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$85.31M
+1.5% vs last quarter
Net shares bought
+4.7M
Est. net flow +$599.23M
Quarter activity
8 bought · 8 sold
0 new · 0 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns GILD?
Who added and who trimmed · Q2 2026
Estimated dollar change per manager (change in shares × this quarter's price). Click a bar to open the manager.
Who owns GILD? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↓ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox | Dodge & Cox | 23.68M | $2.99B | 1.6% | Reduced | -573.3K | -2.4% | -$72.43M |
| 2 | Norges Bank | Norges Bank Investment Management | 21.97M | $2.78B | 0.3% | — | — | — | — |
| 3 | Boston Partners | Boston Partners Global Investors | 6.02M | $761.61M | 0.7% | Added | +1.8M | +41.4% | +$223.10M |
| 4 | Ken Griffin | Citadel Advisors | 3.48M | $439.72M | 0.3% | Reduced | -501.7K | -12.6% | -$63.39M |
| 5 | LSV Asset Management | LSV Asset Management | 2.64M | $333.00M | 0.6% | Reduced | -256.8K | -8.9% | -$32.44M |
| 6 | David Shaw | D.E. Shaw & Co. | 2.29M | $289.92M | 0.2% | Added | +2.1M | +1042.1% | +$264.54M |
| 7 | Jim Simons | Renaissance Technologies | 2.22M | $280.14M | 0.4% | Added | +64.8K | +3.0% | +$8.19M |
| 8 | Israel Englander | Millennium Management | 1.46M | $184.32M | 0.1% | Added | +278.2K | +23.6% | +$35.14M |
| 9 | Steve Cohen | Point72 Asset Management | 1.44M | $181.64M | 0.3% | Added | +1.4M | +16222.5% | +$180.52M |
| 10 | Two Sigma | Two Sigma Investments | 409.17K | $51.70M | 0.0% | Added | +395.7K | +2930.9% | +$49.99M |
| 11 | Ray Dalio | Bridgewater Associates | 290.88K | $36.75M | 0.2% | Added | +110.1K | +60.9% | +$13.92M |
| 12 | John Rogers | Ariel Investments | 195.66K | $24.72M | 0.2% | Reduced | -6.6K | -3.3% | -$835.61K |
| 13 | Chuck Royce | Royce & Associates | 29.00K | $3.66M | 0.0% | Held | 0 | 0.0% | $0 |
| 14 | Fred Alger | Fred Alger Management | 27.96K | $3.53M | 0.0% | Reduced | -12.8K | -31.4% | -$1.62M |
| 15 | Ken Fisher | Fisher Asset Management | 18.93K | $2.39M | 0.0% | Added | +7.8K | +69.7% | +$982.42K |
| 16 | Sprucegrove | Sprucegrove Investment Management | 18.90K | $2.39M | 0.4% | Reduced | -19.0K | -50.1% | -$2.40M |
| 17 | Ron Baron | Baron Capital (BAMCO) | 18.00K | $2.27M | 0.0% | Reduced | -12.0K | -40.0% | -$1.52M |
| 18 | Jeremy Grantham | GMO | 15.81K | $2.00M | 0.0% | Reduced | -20.0K | -55.9% | -$2.53M |
Column filters
No tracked manager sold out of this stock this quarter.
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ro Khanna Politician | Aug 10, 2026 | GILD | GILEAD SCIENCES CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Sep 4, 2026 | 25 days | PTR ↗ |
| Ro Khanna Politician | Jul 7, 2026 | GILD | GILEAD SCIENCES CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Aug 7, 2026 | 31 days | PTR ↗ |
| Ro Khanna Politician | Jul 20, 2026 | GILD | GILEAD SCIENCES CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Aug 7, 2026 | 18 days | PTR ↗ |
| Ro Khanna Politician | Jun 16, 2026 | GILD | GILEAD SCIENCES CMN scanned | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Jul 6, 2026 | 20 days | PTR ↗ |
| Jared Moskowitz Politician | May 6, 2026 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Child | Morgan Stanley Active Assets (5) | Jun 19, 2026 | 44 days | PTR ↗ |
| Jared Moskowitz Politician | May 6, 2026 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Morgan Stanley Active Assets (1) | Jun 19, 2026 | 44 days | PTR ↗ |
| Ro Khanna Politician | May 15, 2026 | GILD | GILEAD SCIENCES CMIN scanned | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Jun 9, 2026 | 25 days | PTR ↗ |
| Ro Khanna Politician | Apr 13, 2026 | GILD | GILEAD SCIENCES CMN scanned | Sale (partial) | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | May 11, 2026 | 28 days | PTR ↗ |
| Josh Gottheimer Politician | Jan 27, 2026 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Morgan Stanley - Select UMA Account # 1 | Feb 26, 2026 | 30 days | PTR ↗ |
| Ro Khanna Politician | Jan 23, 2026 | GILD | GILEAD SCIENCES CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Feb 6, 2026 | 14 days | PTR ↗ |
| Ro Khanna Politician | Jan 29, 2026 | GILD | GILEAD CMN SCIENCES scanned | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | — | — | Feb 6, 2026 | 8 days | PTR ↗ |
| Val T. Hoyle Politician | Sep 23, 2025 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Fidelity Rollover IRA | Oct 10, 2025 | 17 days | PTR ↗ |
| Val T. Hoyle Politician | Oct 29, 2024 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Fidelity Rollover IRA | Sep 12, 2025 | 318 days Late | PTR ↗ |
| Jefferson Shreve Politician | May 12, 2025 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | CRT - Standard Unit Trust | Jun 22, 2025 | 41 days | PTR ↗ |
| Josh Gottheimer Politician | May 14, 2025 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Morgan Stanley - Select UMA Account # 1 | Jun 11, 2025 | 28 days | PTR ↗ |
| Carol D. Miller Politician | Mar 10, 2025 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Matt Miller Investment Management Account | Apr 11, 2025 | 32 days | PTR ↗ |
| Jefferson Shreve Politician | Mar 31, 2025 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | CRT - Standard Unit Trust | Apr 11, 2025 | 11 days | PTR ↗ |
| Josh Gottheimer Politician | Mar 7, 2025 | GILD | Gilead Sciences, Inc. - Common Stock (GILD) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Morgan Stanley - Select UMA Account # 1 | Apr 10, 2025 | 34 days | PTR ↗ |
| Ro Khanna Politician | Nov 15, 2024 | GILD | GILEAD SCIENCES CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Dec 5, 2024 | 20 days | PTR ↗ |
| Ro Khanna Politician | Aug 2, 2024 | GILD | GILEAD SCIENCES CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Sep 6, 2024 | 35 days | PTR ↗ |
| Ro Khanna Politician | May 29, 2024 | GILD | GILEAD SCIENCES CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jun 5, 2024 | 7 days | PTR ↗ |
| Ro Khanna Politician | Mar 25, 2024 | GILD | DC GILEAD SCIENCES CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Apr 5, 2024 | 11 days | PTR ↗ |